Industry Symposium: OSTEOPOROSIS TREATMENTS: starting, sequencing and stopping – what is the long-term outlook?

Sponsored by

Clinical Professor Charles Inderjeeth, Australia

This case-study based discussion between a leading Australian rheumatologist and endocrinologist will cover the following topics in relation to osteoporosis:

  • a clinical assessment of the safety and efficacy data for treatments, including long-term risk/benefit profiles
  • changing therapies and treatment cessation: reversibility differences and off-treatment effects
  • switching and sequential therapy options, including the role of anabolic therapy.